US HB9598 | 2023-2024 | 118th Congress
Status
Spectrum: Bipartisan Bill
Status: Introduced on September 16 2024 - 25% progression
Action: 2024-09-18 - Ordered to be Reported in the Nature of a Substitute by the Yeas and Nays: 38 - 0.
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on September 16 2024 - 25% progression
Action: 2024-09-18 - Ordered to be Reported in the Nature of a Substitute by the Yeas and Nays: 38 - 0.
Text: Latest bill text (Introduced) [PDF]
Summary
To amend the Office of National Drug Control Policy Reauthorization Act to reauthorize such Office, and for other purposes.
Title
Office of National Drug Control Policy Reauthorization Act of 2024
Sponsors
| Rep. James Comer [R-KY] | Rep. Jamie Raskin [D-MD] | Rep. John Duarte [R-CA] | Rep. Jerrold Nadler [D-NY] |
| Rep. Jenniffer Gonzalez-Colon [R-PR] | Rep. Stacey Plaskett [D-VI] |
History
| Date | Chamber | Action |
|---|---|---|
| 2024-09-18 | House | Ordered to be Reported in the Nature of a Substitute by the Yeas and Nays: 38 - 0. |
| 2024-09-18 | House | Committee Consideration and Mark-up Session Held |
| 2024-09-16 | House | Referred to the Committee on Oversight and Accountability, and in addition to the Committees on the Judiciary, and Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
| 2024-09-16 | House | Introduced in House |
Subjects
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/118th-congress/house-bill/9598/all-info |
| Text | https://www.congress.gov/118/bills/hr9598/BILLS-118hr9598ih.pdf |
